Pershing Square Capital Management and Valeant Pharmaceuticals are paying $290 million to settle a lawsuit that alleged their trading in Allergan was illegal, allowing William Ackman to put behind him the last vestiges of an investment that created turmoil at his hedge fund.
from WSJ.com: US Business http://ift.tt/2DzOjIB
Subscribe to:
Post Comments (Atom)
As an AI startup CEO, I pay each employee $18,000 a year to live close to work, and the investment is worth it
Rilla AI Rilla's CEO offers an $18K housing stipend to help employees live close to the AI startup's office. Rilla is working on off...
-
Big Tech is emerging a winner in the new H-1B system, while early-stage startups could lose out. Matthias Balk/nirat/Getty/Getty Images ...
-
Student-loan borrowers said they're worried about higher payments without the SAVE plan. Aaron Hawkins/Getty Images/iStockphoto Tru...
-
Healthcare costs will change for Americans in 2026. Reza Estakhrian/Getty Images Health insurance costs are expected to rise for Americ...
No comments:
Post a Comment